Mobile Emergency Room Articles & Analysis

1 news items found
  • Anavasi Diagnostics Announces FDA EUA Submission for Its COVID-19 Test

    Anavasi Diagnostics announced today that it has submitted the required EUA Clinical Study Data for the AscencioDx®, the molecular diagnostic platform for the detection of RNA indicative of the presence of the SARS-CoV-2/COVID-19 virus, to the Food and Drug Administration (FDA). Anavasi is a medical technology company focused on the development of novel molecular diagnostic testing. It uses a ...


    By Anavasi Diagnostics

Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you